[Eli Lilly and Company](https://www.lillyinvestigatorresearch.com)

Deadline specified in each RFP; check current RFP for active due date

Award size and duration vary by proposal; funding may include financial support and/or study drug

Supports investigator-initiated clinical research in targeted areas defined by publicly posted Requests for Proposals (RFPs).

Grantees retain full regulatory and operational responsibility for the study.

--- ## Description Lilly’s Competitive Clinical Research Grant program is designed to fund external investigator-initiated clinical studies that align with specific areas of interest identified through publicly posted Requests for Proposals (RFPs). Researchers design, sponsor, and conduct the studies independently, with Lilly providing financial support and/or study drug as outlined in the RFP. The program aims to advance knowledge in disease areas of strategic interest to Lilly, such as the impact of lebrikizumab on post-inflammatory dyspigmentation in moderate to severe atopic dermatitis. --- ## Due Dates - Each RFP specifies its own application deadline. - Researchers must consult the [current RFP listings](https://www.lillyinvestigatorresearch.com/competitive-grants#request-for-proposals-how-does-lebrikizumab-impact-post-inflammatory-dyspigmenta) for active opportunities and submission dates. - Late submissions are not accepted. --- ## Funding Amount - Funding level, duration, and the provision of study drug are determined by the specifics of the proposed research and outlined in each RFP. - There is no published minimum or maximum award; budgets are expected to be commensurate with the scope and needs of the proposed study. - Support may include direct financial costs and/or provision of Lilly study drug as appropriate. --- ## Eligibility - Open to external investigators worldwide. - Applicants must be able to assume full regulatory, legal, and operational responsibility for the proposed study (i.e., act as sponsor). - No explicit career stage or institutional restrictions are stated, but applicants must be able to fulfill all regulatory and ethical requirements for independent clinical research. - Proposals must address the specific research question(s) and criteria outlined in the active RFP. --- ## Application Process - Review the current RFPs on the [Lilly Competitive Clinical Grants page](https://www.lillyinvestigatorresearch.com/competitive-grants#request-for-proposals-how-does-lebrikizumab-impact-post-inflammatory-dyspigmenta). - Complete and submit the required proposal form by the deadline indicated in the RFP. - Proposals are reviewed by Lilly’s medical and scientific committees; external review may also be involved. - If selected, the applicant (grantee) is responsible for all aspects of study management, regulatory compliance, and reporting. - The submission process is conducted online via the Lilly Investigator Research portal. --- ## Additional Information - The grant program is intended for studies that are investigator-initiated and managed; Lilly does not serve as the sponsor. - The scope of eligible research is defined by active RFPs; proposals outside these areas are not considered. - Grantees must comply with all applicable laws, regulations, and ethical standards. --- ## External Links - [Lilly Investigator Research Home](https://www.lillyinvestigatorresearch.com) - [Competitive Clinical Grants and RFPs](https://www.lillyinvestigatorresearch.com/competitive-grants#request-for-proposals-how-does-lebrikizumab-impact-post-inflammatory-dyspigmenta) - [Contact Lilly Investigator Research](https://www.lillyinvestigatorresearch.com/contact-us) --- ## Contact Information | Type | Details | |-----------------|------------------------------------------------------------------------------------------| | Program Contact | [Contact Form](https://www.lillyinvestigatorresearch.com/contact-us) | | Funder Website | [Eli Lilly and Company](https://www.lillyinvestigatorresearch.com) |

Competitive Clinical Research Grant

Sign in to see full grant listing